anesthesia glp-1 GLP-1 drugs and aspiration risk

Perioperative Considerations for Patients on GLP1 Agonists

20.28

★★★★☆4.8 (126)

How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like

21.95

★★★★★4.9 (98)

🇬🇧 Perioperative Management of New Popular Agents: GLP-1 Agonists (GLP-1 RA: semaglutide, tirzepatide) These drugs delay gastric emptying → patients may have a “full stomach” despite fasting This increases risk of regurgitation

26.01

★★★★★5.0 (157)

GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus

24.46

★★★★★4.7 (84)

Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia

21.60

★★★★★4.9 (203)

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These

22.47

★★★★★5.0 (176)

Anesthesia Care of the Patient on a GLP-1 Receptor Agonist by aanapublishing

28.21

★★★★★4.8 (132)